» Articles » PMID: 28733216

SLDAssay: A Software Package and Web Tool for Analyzing Limiting Dilution Assays

Overview
Publisher Elsevier
Date 2017 Jul 23
PMID 28733216
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Serial limiting dilution (SLD) assays are used in many areas of infectious disease related research. This paper presents SLDAssay, a free and publicly available R software package and web tool for analyzing data from SLD assays. SLDAssay computes the maximum likelihood estimate (MLE) for the concentration of target cells, with corresponding exact and asymptotic confidence intervals. Exact and asymptotic goodness of fit p-values, and a bias-corrected (BC) MLE are also provided. No other publicly available software currently implements the BC MLE or the exact methods. For validation of SLDAssay, results from Myers et al. (1994) are replicated. Simulations demonstrate the BC MLE is less biased than the MLE. Additionally, simulations demonstrate that exact methods tend to give better confidence interval coverage and goodness-of-fit tests with lower type I error than the asymptotic methods. Additional advantages of using exact methods are also discussed.

Citing Articles

The role of Nef in the long-term persistence of the replication-competent HIV reservoir in South African women.

Ismail S, Sebaa S, Abrahams B, Nason M, Mumby M, Dikeakos J bioRxiv. 2024; .

PMID: 39554110 PMC: 11565997. DOI: 10.1101/2024.11.01.621615.


Quantifying the HIV reservoir with dilution assays and deep viral sequencing.

Lotspeich S, Richardson B, Baldoni P, Enders K, Hudgens M Biometrics. 2024; 80(1).

PMID: 38364812 PMC: 10873562. DOI: 10.1093/biomtc/ujad018.


The Effects of Human Immunodeficiency Virus Type 1 (HIV-1) Antigen-Expanded Specific T-Cell Therapy and Vorinostat on Persistent HIV-1 Infection in People With HIV on Antiretroviral Therapy.

Gay C, Hanley P, Falcinelli S, Kuruc J, Pedersen S, Kirchherr J J Infect Dis. 2024; 229(3):743-752.

PMID: 38349333 PMC: 10938201. DOI: 10.1093/infdis/jiad423.


Aminobisphosphonates reactivate the latent reservoir in people living with HIV-1.

Sanz M, Weideman A, Ward A, Clohosey M, Garcia-Recio S, Selitsky S Front Immunol. 2023; 14:1219250.

PMID: 37744358 PMC: 10516574. DOI: 10.3389/fimmu.2023.1219250.


Aminobisphosphonates reactivate the latent reservoir in people living with HIV-1.

Sanz M, Weideman A, Ward A, Clohosey M, Garcia-Recio S, Selitsky S bioRxiv. 2023; .

PMID: 36798291 PMC: 9934553. DOI: 10.1101/2023.02.07.527421.


References
1.
Macken C . Design and analysis of serial limiting dilution assays with small sample sizes. J Immunol Methods. 1999; 222(1-2):13-29. DOI: 10.1016/s0022-1759(98)00133-1. View

2.
Archin N, Bateson R, Tripathy M, Crooks A, Yang K, Dahl N . HIV-1 expression within resting CD4+ T cells after multiple doses of vorinostat. J Infect Dis. 2014; 210(5):728-35. PMC: 4148603. DOI: 10.1093/infdis/jiu155. View

3.
Crooks A, Bateson R, Cope A, Dahl N, Griggs M, Kuruc J . Precise Quantitation of the Latent HIV-1 Reservoir: Implications for Eradication Strategies. J Infect Dis. 2015; 212(9):1361-5. PMC: 4601910. DOI: 10.1093/infdis/jiv218. View

4.
Myers L, McQuay L, Hollinger F . Dilution assay statistics. J Clin Microbiol. 1994; 32(3):732-9. PMC: 263116. DOI: 10.1128/jcm.32.3.732-739.1994. View

5.
Soriano-Sarabia N, Archin N, Bateson R, Dahl N, Crooks A, Kuruc J . Peripheral Vγ9Vδ2 T Cells Are a Novel Reservoir of Latent HIV Infection. PLoS Pathog. 2015; 11(10):e1005201. PMC: 4608739. DOI: 10.1371/journal.ppat.1005201. View